Condition
Diabetic Vascular Disease
Diabetic vascular disease encompasses the accelerated atherosclerosis and microvascular damage that occur in patients with diabetes mellitus. Diabetes roughly doubles the risk of cardiovascular events, and cardiovascular disease is the leading cause of death in people with diabetes. The damage occurs at both the large-vessel level — driving coronary disease, stroke, and peripheral artery disease — and the microvascular level, contributing to retinopathy, nephropathy, and neuropathy. Importantly, newer diabetes medications (SGLT2 inhibitors and GLP-1 receptor agonists) provide direct cardiovascular benefit that goes beyond glucose lowering. Dr. Kedan manages cardiovascular protection in patients with diabetes as a top priority and coordinates closely with primary care and endocrinology.
What Cardiolucent Evaluates
- Cardiovascular risk assessment integrating diabetes duration, control, and end-organ effects
- Advanced lipid panel including apolipoprotein B and lipoprotein(a)
- Coronary calcium scoring and other imaging when indicated
- Ankle-brachial index and lower-extremity vascular assessment
- Echocardiography with POCUS to screen for early structural changes
- Coordination of SGLT2 inhibitor and GLP-1 receptor agonist therapy with primary care or endocrinology
- Aggressive blood pressure, lipid, and antiplatelet management
Common Symptoms
- Often silent — many patients have advanced disease before symptoms appear
- Chest pain or pressure, sometimes atypical or absent due to neuropathy
- Shortness of breath or reduced exercise tolerance
- Leg pain with walking (claudication) or non-healing foot wounds
- Symptoms of stroke or transient ischemic attack
- Subtle heart failure symptoms — fatigue, swelling, weight gain
Risk Factors
- Type 1 or type 2 diabetes
- Longer duration of diabetes
- Suboptimal glycemic control
- Concurrent hypertension
- Elevated cholesterol, especially LDL and lipoprotein(a)
- Obesity, particularly central adiposity
- Chronic kidney disease
- Tobacco use
- Family history of cardiovascular disease
How Cardiolucent Approaches Treatment
Cardiovascular protection in diabetes is built on several pillars: aggressive lipid lowering with high-intensity statins (often with ezetimibe and PCSK9 inhibitors when needed) to drive LDL well below standard targets; strict blood pressure control; use of SGLT2 inhibitors and GLP-1 receptor agonists, which independently reduce cardiovascular events; antiplatelet therapy for selected patients; and intensive lifestyle support. Dr. Kedan personally manages these decisions and coordinates with primary care or endocrinology on glucose management.
Common Questions
Frequently Asked Questions
What is diabetic vascular disease?
Why is cardiovascular risk so much higher with diabetes?
What is the role of SGLT2 inhibitors and GLP-1 receptor agonists?
How aggressively should my cholesterol be lowered?
Should I take aspirin?
Why do I need a cardiologist if I see an endocrinologist?
How often should I be evaluated?
What lifestyle changes matter most?
Can I reverse diabetic vascular damage?
How do I schedule a consultation?
Explore
Related Conditions
Hyperlipidemia
Hyperlipidemia is elevation of cholesterol or other blood lipids and is one of the most powerful modifiable risk factors for heart disease.
Learn moreMetabolic Syndrome
Metabolic syndrome is a cluster of cardiovascular risk factors — central obesity, hypertension, dyslipidemia, and elevated glucose — that compound to drive heart disease.
Learn moreObesity
Obesity is excess body fat that drives hypertension, diabetes, sleep apnea, atrial fibrillation, and heart failure, and is now meaningfully treatable.
Learn moreObstructive Sleep Apnea
Obstructive sleep apnea is repeated upper-airway collapse during sleep that drives hypertension, atrial fibrillation, heart failure, and stroke risk.
Learn more